12-94267198-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005761.3(PLXNC1):c.3597+1973T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 152,178 control chromosomes in the GnomAD database, including 1,839 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 1839 hom., cov: 33)
Consequence
PLXNC1
NM_005761.3 intron
NM_005761.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 3.04
Publications
4 publications found
Genes affected
PLXNC1 (HGNC:9106): (plexin C1) This gene encodes a member of the plexin family. Plexins are transmembrane receptors for semaphorins, a large family of proteins that regulate axon guidance, cell motility and migration, and the immune response. The encoded protein and its ligand regulate melanocyte adhesion, and viral semaphorins may modulate the immune response by binding to this receptor. The encoded protein may be a tumor suppressor protein for melanoma. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jan 2011]
CEP83 (HGNC:17966): (centrosomal protein 83) The protein encoded by this gene is a centriolar protein involved in primary cilium assembly. Defects in this gene have been associated with infantile nephronophthisis and intellectual disability. [provided by RefSeq, Oct 2016]
CEP83 Gene-Disease associations (from GenCC):
- nephronophthisis 18Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.156 AC: 23735AN: 152060Hom.: 1839 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
23735
AN:
152060
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.156 AC: 23739AN: 152178Hom.: 1839 Cov.: 33 AF XY: 0.155 AC XY: 11524AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
23739
AN:
152178
Hom.:
Cov.:
33
AF XY:
AC XY:
11524
AN XY:
74380
show subpopulations
African (AFR)
AF:
AC:
6164
AN:
41518
American (AMR)
AF:
AC:
2924
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
515
AN:
3470
East Asian (EAS)
AF:
AC:
843
AN:
5174
South Asian (SAS)
AF:
AC:
652
AN:
4822
European-Finnish (FIN)
AF:
AC:
1560
AN:
10592
Middle Eastern (MID)
AF:
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10459
AN:
67996
Other (OTH)
AF:
AC:
372
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1028
2056
3083
4111
5139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
489
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.